Mannkind (MNKD) Change in Acquisitions & Divestments (2011 - 2026)
Mannkind (MNKD) reported Change in Acquisitions & Divestments of $30.9 million for Q1 2026, down 38.67% year-over-year from $50.4 million in Q1 2025, and down 56.77% on a QoQ basis from $71.5 million in Q4 2025.
Mannkind (MNKD) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $30.9 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 38.67% year-over-year to $30.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195.8 million (up 126.25% YoY) and the FY2025 annual result came in at $215.3 million, up 270.42% from the prior year.
- Change in Acquisitions & Divestments declined to $30.9 million in Q1 2026 per MNKD's latest filing, from $71.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $71.5 million in Q4 2025 and bottomed at -$77.2 million in Q4 2024.
- The 5-year median for Change in Acquisitions & Divestments is $29.3 million (2022), against an average of $31.2 million.
- The widest annual swing landed in 2022, when Change in Acquisitions & Divestments jumped 892200.0%; it then slumped 390.65% in 2024.
- Tracing MNKD's Change in Acquisitions & Divestments over 5 years: stood at $24.8 million in 2022, then gained by 7.28% to $26.6 million in 2023, then tumbled by 390.65% to -$77.2 million in 2024, then soared by 192.62% to $71.5 million in 2025, then plunged by 56.77% to $30.9 million in 2026.
- Per Business Quant, the three latest MNKD Change in Acquisitions & Divestments figures stand at $30.9 million (Q1 2026), $71.5 million (Q4 2025), and $42.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.91 Mn |
| Mar 31, 2026 | 30.91 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Dec 31, 2024 | -77.19 Mn |
| Dec 31, 2024 | -77.19 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Sep 30, 2023 | 23.53 Mn |
| Sep 30, 2023 | 23.53 Mn |
| Jun 30, 2023 | 46.98 Mn |
| Jun 30, 2023 | 46.98 Mn |
| Mar 31, 2023 | 22.10 Mn |
| Mar 31, 2023 | 22.10 Mn |
| Dec 31, 2022 | 24.76 Mn |
| Dec 31, 2022 | 24.76 Mn |
| Sep 30, 2022 | 29.28 Mn |
| Sep 30, 2022 | 29.28 Mn |
| Jun 30, 2022 | 26.77 Mn |
| Jun 30, 2022 | 26.77 Mn |
| Mar 31, 2022 | 26.54 Mn |
| Mar 31, 2022 | 26.54 Mn |
| Dec 31, 2021 | -46.66 Mn |
| Dec 31, 2021 | -46.66 Mn |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2020 | 20.00 Mn |
| Mar 31, 2020 | 20.00 Mn |
| Dec 31, 2019 | -2,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Mar 31, 2011 | 3.83 Mn |
| Mar 31, 2011 | 3.83 Mn |